Low Response in Metastatic Breast Cancer Study Despite Precision Approach Shows Real World Challenge | Pharmacogenomics Reporter | Clinical Genomics | GenomeWeb

Low Response in Metastatic Breast Cancer Study Despite Precision Approach Shows Real World Challenge | Pharmacogenomics Reporter | Clinical Genomics | GenomeWeb

Low Response in Metastatic Breast Cancer Study Despite Precision Approach Shows Real World Challenge

March 26, 2014

• Type size:-+
• Email
• Printer-friendly version
• RSS Feed

By Turna Ray

Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter.